JP2024546844A5 - - Google Patents
Info
- Publication number
- JP2024546844A5 JP2024546844A5 JP2024535383A JP2024535383A JP2024546844A5 JP 2024546844 A5 JP2024546844 A5 JP 2024546844A5 JP 2024535383 A JP2024535383 A JP 2024535383A JP 2024535383 A JP2024535383 A JP 2024535383A JP 2024546844 A5 JP2024546844 A5 JP 2024546844A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- solid form
- ray powder
- powder diffraction
- form according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290136P | 2021-12-16 | 2021-12-16 | |
| US63/290,136 | 2021-12-16 | ||
| PCT/US2022/081795 WO2023114995A1 (en) | 2021-12-16 | 2022-12-16 | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546844A JP2024546844A (ja) | 2024-12-26 |
| JP2024546844A5 true JP2024546844A5 (https=) | 2025-12-04 |
Family
ID=85172741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535383A Pending JP2024546844A (ja) | 2021-12-16 | 2022-12-16 | ピラゾロ［３，４－ｄ］ピリミジン化合物の固体形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12012412B2 (https=) |
| EP (1) | EP4448529A1 (https=) |
| JP (1) | JP2024546844A (https=) |
| KR (1) | KR20240119299A (https=) |
| CN (1) | CN118401525A (https=) |
| AU (2) | AU2022416644B2 (https=) |
| CA (1) | CA3242577A1 (https=) |
| IL (1) | IL313314A (https=) |
| MX (1) | MX2024007517A (https=) |
| TW (1) | TW202333676A (https=) |
| WO (1) | WO2023114995A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12012412B2 (en) * | 2021-12-16 | 2024-06-18 | Pfizer Inc. | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
| AU2024329573A1 (en) * | 2023-08-22 | 2026-04-02 | Cardurion Pharmaceuticals, Inc. | Pyrazolo[3,4-d]pyrimidinone compounds for the treatment of chronic heart failure |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| RS52166B (sr) * | 2007-05-11 | 2012-08-31 | Pfizer Inc. | Amino-heterociklična jedinjenja |
| CN109893653A (zh) * | 2017-12-11 | 2019-06-18 | 王慧敏 | Pde9抑制剂的新用途 |
| US12012412B2 (en) | 2021-12-16 | 2024-06-18 | Pfizer Inc. | Solid forms of pyrazolo[3,4-d]pyrimidine compounds |
-
2022
- 2022-12-16 US US18/082,622 patent/US12012412B2/en active Active
- 2022-12-16 CN CN202280083751.7A patent/CN118401525A/zh active Pending
- 2022-12-16 AU AU2022416644A patent/AU2022416644B2/en active Active
- 2022-12-16 IL IL313314A patent/IL313314A/en unknown
- 2022-12-16 EP EP22854339.3A patent/EP4448529A1/en active Pending
- 2022-12-16 JP JP2024535383A patent/JP2024546844A/ja active Pending
- 2022-12-16 WO PCT/US2022/081795 patent/WO2023114995A1/en not_active Ceased
- 2022-12-16 MX MX2024007517A patent/MX2024007517A/es unknown
- 2022-12-16 TW TW111148528A patent/TW202333676A/zh unknown
- 2022-12-16 CA CA3242577A patent/CA3242577A1/en active Pending
- 2022-12-16 KR KR1020247023041A patent/KR20240119299A/ko active Pending
-
2024
- 2024-05-06 US US18/655,795 patent/US20240300961A1/en active Pending
-
2025
- 2025-12-03 AU AU2025275149A patent/AU2025275149A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024546844A5 (https=) | ||
| JP2022540668A5 (https=) | ||
| JP2015533168A5 (https=) | ||
| CA1155116A (en) | Phenyl piperazine derivatives having antiagressive activity | |
| TWI359803B (en) | Tetraphenylnaphthalene derivatives and organic lig | |
| RU2008123055A (ru) | СОЛИ ИНГИБИТОРА ФАКТОРА Ха, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ ТРОМБОЗА И СПОСОБ ИНГИБИРОВАНИЯ КОАГУЛЯЦИИ ОБРАЗЦОВ КРОВИ | |
| JP2023546125A5 (https=) | ||
| JP2024508526A5 (https=) | ||
| JP2022542803A5 (https=) | ||
| JP2025511847A5 (https=) | ||
| CN100509789C (zh) | 替米沙坦的晶体钠盐及其作为血管紧张素的拮抗药的用途 | |
| RU2014122261A (ru) | Форма iv ивабрадина гидрохлорида | |
| WO2019196714A1 (zh) | 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途 | |
| CA2578596C (en) | Substituted phenylaminothiazoles and their use | |
| CA2626451A1 (en) | Cyclopropylacetic acid derivatives and use thereof | |
| JPS59118783A (ja) | 新規の置換された１，４−ジヒドロピリジン、その製造法及びこれを診断剤として使用する方法 | |
| CA2488193A1 (en) | Inhibitors of the gpib -vwf interaction, their preparation and use | |
| JP2024514090A5 (https=) | ||
| JP4319148B2 (ja) | Ｓ−（−）−アムロジピンニコチネート及びその製造方法 | |
| JP2022540678A5 (https=) | ||
| JP2005504795A5 (https=) | ||
| WO2004000813A1 (ja) | フェノキシピリジン誘導体又はその塩 | |
| US4250316A (en) | Pyridyl guanidine anti-ulcer agents | |
| US4289876A (en) | Antisecretory agents | |
| JPH08507299A (ja) | ヒドロキシメチルフラザンカルボン酸誘導体及びこれを心臓血管系疾患の治療に使用する方法 |